Novo, Lilly begin to sell obesity medications directly to employers

Building on the growing success of offering cheaper cash-pay prices to consumers for their GLP-1 weight loss drugs, Novo Nordisk and Eli Lilly are setting up programs to work directly with employers. Waltz Health, an ...